Question 1

What is Amphastar Pharmaceuticals, Inc.'s WACC?

Accepted Answer

Amphastar Pharmaceuticals, Inc. (AMPH) has a Weighted Average Cost of Capital (WACC) of 6.19%. This is calculated using a Cost of Equity of 7.56% (via CAPM with a beta of 0.62) and a pre-tax Cost of Debt of 5.04%, with an equity weight of 61.83% in the capital structure.

Question 2

Is Amphastar Pharmaceuticals, Inc.'s WACC high or low?

Accepted Answer

Amphastar Pharmaceuticals, Inc.'s WACC of 6.19% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Question 3

How is Amphastar Pharmaceuticals, Inc.'s WACC calculated?

Accepted Answer

Amphastar Pharmaceuticals, Inc.'s WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 7.56% is derived from the CAPM model using a beta of 0.62. The pre-tax Cost of Debt (Rd) is 5.04%. The capital structure is 61.83% equity and 38.17% debt.

Amphastar Pharmaceuticals, Inc. (AMPH) — WACC 分析

WACC 构成

解读

Amphastar Pharmaceuticals, Inc.（AMPH）WACC：6.19%

WACC计算器

Amphastar Pharmaceuticals, Inc.（AMPH） WACC 解读

AMPH 公司分析

AMPH DCF 估值

继续做同行对比